BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 18789356)

  • 1. Imaging genetics in ADHD: a focus on cognitive control.
    Durston S; de Zeeuw P; Staal WG
    Neurosci Biobehav Rev; 2009 May; 33(5):674-89. PubMed ID: 18789356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding genes, environment and their interaction in attention-deficit hyperactivity disorder: is there a role for neuroimaging?
    Plomp E; Van Engeland H; Durston S
    Neuroscience; 2009 Nov; 164(1):230-40. PubMed ID: 19619618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging genetics in ADHD.
    Durston S
    Neuroimage; 2010 Nov; 53(3):832-8. PubMed ID: 20206707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic interaction analysis for DRD4 and DAT1 genes in a group of Mexican ADHD patients.
    Gabriela ML; John DG; Magdalena BV; Ariadna GS; Francisco de LP; Liz SM; Lino PC; Josefina RG; Ernesto RZ; Carlos CF
    Neurosci Lett; 2009 Feb; 451(3):257-60. PubMed ID: 19146920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Converging methods in studying attention-deficit/hyperactivity disorder: what can we learn from neuroimaging and genetics?
    Durston S
    Dev Psychopathol; 2008; 20(4):1133-43. PubMed ID: 18838034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candidate gene studies of attention-deficit/hyperactivity disorder.
    Faraone SV; Khan SA
    J Clin Psychiatry; 2006; 67 Suppl 8():13-20. PubMed ID: 16961425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine-serotonin interactions in attention-deficit hyperactivity disorder (ADHD).
    Oades RD
    Prog Brain Res; 2008; 172():543-65. PubMed ID: 18772050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine risk and paternal ADHD symptomatology associated with ADHD symptoms in four and a half-year-old boys.
    Auerbach JG; Atzaba-Poria N; Berger A; Landau R; Arbelle S; Raz Y; Ebstein R
    Psychiatr Genet; 2010 Aug; 20(4):160-5. PubMed ID: 20421851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combination of DRD4 and DAT1 genotypes is an important risk factor for attention deficit disorder with hyperactivity families living in Santiago, Chile].
    Henríquez B H; Henríquez H M; Carrasco Ch X; Rothhammer A P; Llop R E; Aboitiz F; Rothhammer E F
    Rev Med Chil; 2008 Jun; 136(6):719-24. PubMed ID: 18769827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review: Genetics of attention deficit/hyperactivity disorder.
    Wallis D; Russell HF; Muenke M
    J Pediatr Psychol; 2008; 33(10):1085-99. PubMed ID: 18522996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic haplotype as a predictor of spatial inattention in children with attention-deficit/hyperactivity disorder.
    Bellgrove MA; Johnson KA; Barry E; Mulligan A; Hawi Z; Gill M; Robertson I; Chambers CD
    Arch Gen Psychiatry; 2009 Oct; 66(10):1135-42. PubMed ID: 19805704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of the biological bases of ADHD: what have we learned from imaging studies?
    Durston S
    Ment Retard Dev Disabil Res Rev; 2003; 9(3):184-95. PubMed ID: 12953298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Schizotypy, attention deficit hyperactivity disorder, and dopamine genes.
    Ettinger U; Joober R; DE Guzman R; O'driscoll GA
    Psychiatry Clin Neurosci; 2006 Dec; 60(6):764-7. PubMed ID: 17109713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The genetics of attention-deficit/hyperactivity disorder.
    Coghill D; Banaschewski T
    Expert Rev Neurother; 2009 Oct; 9(10):1547-65. PubMed ID: 19831843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular genetics of attention-deficit/hyperactivity disorder.
    Faraone SV; Perlis RH; Doyle AE; Smoller JW; Goralnick JJ; Holmgren MA; Sklar P
    Biol Psychiatry; 2005 Jun; 57(11):1313-23. PubMed ID: 15950004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relations between multi-informant assessments of ADHD symptoms, DAT1, and DRD4.
    Gizer IR; Waldman ID; Abramowitz A; Barr CL; Feng Y; Wigg KG; Misener VL; Rowe DC
    J Abnorm Psychol; 2008 Nov; 117(4):869-80. PubMed ID: 19025233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Some ADHD polymorphisms (in genes DAT1, DRD2, DRD3, DBH, 5-HTT) in case-control study of 100 subjects 6-10 age.
    Kopecková M; Paclt I; Petrásek J; Pacltová D; Malíková M; Zagatová V
    Neuro Endocrinol Lett; 2008 Apr; 29(2):246-51. PubMed ID: 18404133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Genomic endophenotypes of attention deficit hyperactivity disorder].
    Fernández-Jaén A; Fernández-Mayoralas DM; Calleja-Pérez B; Muñoz-Jareño N; López-Arribas S
    Rev Neurol; 2012 Feb; 54 Suppl 1():S81-7. PubMed ID: 22374776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Structural and functional neuroanatomy of attention-deficit hyperactivity disorder (ADHD)].
    Emond V; Joyal C; Poissant H
    Encephale; 2009 Apr; 35(2):107-14. PubMed ID: 19393378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of DRD4 and DAT1 genotype on fronto-striatal gray matter volumes in a sample of subjects with attention deficit hyperactivity disorder, their unaffected siblings, and controls.
    Durston S; Fossella JA; Casey BJ; Hulshoff Pol HE; Galvan A; Schnack HG; Steenhuis MP; Minderaa RB; Buitelaar JK; Kahn RS; van Engeland H
    Mol Psychiatry; 2005 Jul; 10(7):678-85. PubMed ID: 15724142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.